Status:
COMPLETED
Clinical Study on Sitagliptin for Assessment of Glucose-lowering Effects (0431-045)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Diabetes Mellitus, Non-Insulin-Dependent
Eligibility:
All Genders
20-69 years
Phase:
PHASE2
Brief Summary
A clinical study determines the safety and efficacy of sitagliptin (MK0431) in patients with Type 2 diabetes mellitus who have inadequate glycemic control on diet/exercise therapy
Eligibility Criteria
Inclusion
- Patients Have Type 2 Diabetes Mellitus On Diet/Exercise Therapy
Exclusion
- Patients Have Type 1 Diabetes Mellitus
Key Trial Info
Start Date :
July 3 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 13 2006
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT00758069
Start Date
July 3 2005
End Date
February 13 2006
Last Update
May 5 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.